Skip to main content
. 2018 Jul 25;77(11):1549–1557. doi: 10.1136/annrheumdis-2018-213512

Table 3.

GLADEL–PANLAR recommendations for cardiac and pulmonary manifestations

Treatment recommendations Quality of the evidence Strength of recommendation
Cardiac manifestations
In adult patients with lupus-related acute pericarditis
Use SOC plus colchicine over SOC plus NSAIDs or belimumab. Low Weak
Pulmonary manifestations
In adult patient with lupus-related diffuse alveolar haemorrhage
Use intravenous GCs plus CYC and/or intravenous Ig and/or TPE and/or RTX over GCs alone. Very low Strong*

*Strong recommendation supported on possible benefits in the context of a life-threatening situation.

CYC, cyclophosphamide; GC, glucocorticoid; GLADEL, Grupo Latino Americano de Estudio del Lupus; Ig, immunoglobulin; NSAID, non-steroidal anti-inflammatory drug; PANLAR, Pan-American League of Associations of Rheumatology; RTX, rituximab; SOC, standard of care; TPE, therapeutic plasma exchange.